I could not find any information about the S1 PR, that actually has information in it. As far as the article it is old news that is wrong because they do have FDA trials. With that said the trials have yet to begin, so we will see.
Anyone is welcome to provide links to disprove comments made in the article. Otherwise, it's very discouraging to read! It may be old, but it's still relevant to this stock. I missed it, others might have also. I'm just putting it out there, make your own decisions. I'm all out and I had a HUGE position...